Chemoinformaics analysis of simalikalactone d
| Molecular Weight | 346.471 | nRot | 2 |
| Heavy Atom Molecular Weight | 316.231 | nRig | 19 |
| Exact Molecular Weight | 346.226 | nRing | 4 |
| Solubility: LogS | -3.664 | nHRing | 4 |
| Solubility: LogP | 4.136 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 58.0098 |
| nHD | 0 | BPOL | 36.9882 |
| QED | 0.742 |
| Synth | 3.32 |
| Natural Product Likeliness | 2.225 |
| NR-PPAR-gamma | 0.763 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.08 |
| Pgp-sub | 0.02 |
| HIA | 0.005 |
| CACO-2 | -4.764 |
| MDCK | 0.0000152 |
| BBB | 0.022 |
| PPB | 0.995533 |
| VDSS | 0.517 |
| FU | 0.00991128 |
| CYP1A2-inh | 0.943 |
| CYP1A2-sub | 0.652 |
| CYP2c19-inh | 0.909 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.879 |
| CYP2c9-sub | 0.951 |
| CYP2d6-inh | 0.921 |
| CYP2d6-sub | 0.776 |
| CYP3a4-inh | 0.651 |
| CYP3a4-sub | 0.207 |
| CL | 14.031 |
| T12 | 0.472 |
| hERG | 0.032 |
| Ames | 0.309 |
| ROA | 0.639 |
| SkinSen | 0.93 |
| Carcinogencity | 0.109 |
| EI | 0.825 |
| Respiratory | 0.087 |
| NR-Aromatase | 0.479 |
| Antiviral | Yes |
| Prediction | 0.767887 |